Brilliant BioSciences Inc. is organized around providing simple solutions for research and drug discovery needs. Serving the needs of the drug discovery industry and individual research labs, the firm provides FRET-based GPCR binding assays technology using proprietary GPCR fusions with externally expressed fluorescent proteins and offers kit based binding assays, custom labeled GPCRs and fluorescent ligands. GPCRs with short N-terminal tails that have traditionally labeled at C terminus may now be expressed on the extracellular site and used in FRET based binding with fluorescent labeled ligands. Brilliant BioSciences Inc. also offers traditional radioligand receptor binding services for assay validation and custom peptide synthesis
